The role of thrombolytic drugs in the management of myocardial infarction : Comparative clinical trials
作者： W. D. Weaver
DOI: 10.1093/EURHEARTJ/17.SUPPL_F.9
关键词:
摘要: … , thrombolytic drugs are … drug provides the most optimal therapy remains controversial1'1. Evidence from many clinical trials now indicates that two characteristics of a thrombolytic drug …
oup.com
sci-hub.se 参考文章(22)
R.G. Wilcox, C.G. Olsson, A.M. Skene, G. Von Der Lippe, G. Jensen, J.R. Hampton, For The Asset Study Group, TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET) The Lancet. ,vol. 332, pp. 525- 530 ,(1988) , 10.1016/S0140-6736(88)92656-6
GRUPPOITALIANOPERLOSTUDIODELL, EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION The Lancet. ,vol. 327, pp. 397- 402 ,(1986) , 10.1016/S0140-6736(86)92368-8
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The New England Journal of Medicine. ,vol. 329, pp. 673- 682 ,(1993) , 10.1056/NEJM199309023291001
Christoph Bode, Richard W. Smalling, Gunther Berg, Curtis Burnett, Gerald Lorch, John M. Kalbfleisch, Robert Chernoff, Leonard G. Christie, Robert L. Feldman, A. Allen Seals, W. Douglas Weaver, Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activator) in Patients With Acute Myocardial Infarction Circulation. ,vol. 94, pp. 891- 898 ,(1996) , 10.1161/01.CIR.94.5.891
Richard W Smalling, Christoph Bode, John Kalbfleisch, Semi Sen, Peter Limbourg, Florian Forycki, Gabriel Habib, Robert Feldman, Stefan Hohnloser, Allen Seals, None, More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction Circulation. ,vol. 91, pp. 2725- 2732 ,(1995) , 10.1161/01.CIR.91.11.2725
B J Gersh, J L Anderson, Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable? Circulation. ,vol. 88, pp. 296- 306 ,(1993) , 10.1161/01.CIR.88.1.296
Ulrich Martin, Rainer Bader, Erwin Böhm, Ulrich Kohnert, Erika Möllendorf, Stephan Fischer, Gisbert Sponer, BM 06.022: A Novel Recombinant Plasminogen Activator Cardiovascular Drug Reviews. ,vol. 11, pp. 299- 311 ,(1993) , 10.1111/J.1527-3466.1993.TB00193.X
R.J. Simes, Eric J. Topol, David R. Holmes, Harvey D. White, Wolfgang R. Rutsch, Alec Vahanian, Maarten L. Simoons, Douglas Morris, Amadeo Betriu, Robert M. Califf, Allan M. Ross, Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion : importance of early and complete infarct artery reperfusion Circulation. ,vol. 91, pp. 1923- 1928 ,(1995) , 10.1161/01.CIR.91.7.1923
Karl-Ludwig Neuhaus, Rainer von Essen, Albrecht Vogt, Ulrich Tebbe, Jörg Rustige, Hans-Joachim Wagner, Karl-Friedrich Appel, Ulrich Stienen, Reinhard König, Wolfgang Meyer-Sabellek, Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study Journal of the American College of Cardiology. ,vol. 24, pp. 55- 60 ,(1994) , 10.1016/0735-1097(94)90541-X
Christopher P Cannon, Carolyn H McCabe, Daniel J Diver, Steve Herson, Robert M Greene, Prediman K Shah, Raphael F Sequeira, Ferdinand Leya, James M Kirshenbaum, Raymond D Magorien, Sebastian T Palmeri, Vicki Davis, C Michael Gibson, W Kenneth Poole, Eugene Braunwald, TIMI 4 investigators, Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial Journal of the American College of Cardiology. ,vol. 24, pp. 1602- 1610 ,(1994) , 10.1016/0735-1097(94)90163-5